The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy
Novel treatment moves into first clinical trial for adults with hard-to-treat acute myeloid leukemiaAURORA, Colo., April 2, 2026 /PRNewswire/ --...
Read moreDetails